Nursing Medication card - Sedative Hypnotics, Opioids, Neuromuscular Blockers, Anticholinergics (Kor/Eng)
2025. 8. 3. 21:09ㆍIn Canada/nursing study
반응형
Sedative Hypnotics, Opioids, Neuromuscular Blockers, Anticholinergics
(간호약물카드 - 진정수면제, 오피오이드, 근이완제, 항콜린제)
Sedative Hypnotics (진정 수면제)
Barbiturates (바르비투르산염)
DrugSecobarbitalThiopental
| Indication (적응증) | Short-term insomnia, pre-op sedation | Induction of anesthesia, short surgical procedures |
| Therapeutic Effects (효과) | CNS depression, sedation | Rapid anesthesia induction |
| Absorption | Oral (secobarbital), IV (thiopental) | IV |
| Distribution | Widely, cross BBB | Widely |
| Metabolism/Excretion | Hepatic, renal | Hepatic, renal |
| ADE | Respiratory depression, drowsiness, hypotension | Hypotension, respiratory depression |
| Nurse Consideration | Monitor airway, CNS status | Ensure airway management, respiratory monitoring |
Benzodiazepines (벤조디아제핀계)
DrugDiazepamMidazolam
| Indication (적응증) | Anxiety, seizures, muscle spasms | Pre-op sedation, procedural sedation |
| Therapeutic Effects | Anxiolytic, muscle relaxant | Sedation, amnesia |
| Absorption | Oral, IV, IM | IV, IM |
| Distribution | Cross BBB, placenta | Rapid distribution |
| Metabolism/Excretion | Hepatic metabolism | Hepatic metabolism |
| ADE | Drowsiness, hypotension, respiratory depression | Respiratory depression, hypotension |
| Nurse Consideration | Fall risk, monitor vitals | Monitor respiratory status, O2 sat |
Opioids (오피오이드 진통제)
DrugMorphineFentanylSufentanil
| Indication | Severe pain | Anesthesia adjunct | Anesthesia adjunct |
| Therapeutic Effects | Analgesia | Analgesia, sedation | Potent analgesia |
| Absorption | IV, IM, oral | IV, transdermal | IV |
| Distribution | Widely | High lipid solubility | Rapid |
| Metabolism/Excretion | Hepatic, renal | Hepatic | Hepatic |
| ADE | Respiratory depression, constipation | Respiratory depression, bradycardia | Severe respiratory depression |
| Nurse Consideration | Monitor RR, sedation, BP | Close O2 monitoring | ICU setting monitoring only |
Neuromuscular Blocking Agents (신경근 차단제)
Depolarizing Agent (탈분극성 근이완제)
DrugSuccinylcholine
| Indication | Intubation, rapid sequence induction |
| Therapeutic Effects | Short-term muscle paralysis |
| Absorption | IV |
| Distribution | Rapid |
| Metabolism/Excretion | Plasma cholinesterase |
| ADE | Malignant hyperthermia, hyperkalemia |
| Nurse Consideration | Emergency airway, malignant hyperthermia protocol |
Non-depolarizing Agents (비탈분극성 근이완제)
DrugRocuroniumPancuroniumVecuronium
| Indication | Intubation, surgical paralysis | Surgical paralysis | ICU paralysis |
| Therapeutic Effects | Skeletal muscle relaxation | Prolonged relaxation | Intermediate-acting relaxant |
| Onset | Rapid | Intermediate | Intermediate |
| Duration | Short | Long | Intermediate |
| ADE | Hypotension, residual paralysis | Tachycardia | Bradycardia, hypotension |
| Nurse Consideration | Always with ventilator support | Monitor TOF (Train-of-Four) | Reverse with neostigmine if needed |
Anticholinergics (항콜린제)
(Mnemonic: Can’t see, can’t spit, can’t pee, can’t shit)
DrugAtropineScopolamine
| Indication | Bradycardia, pre-op secretions | Motion sickness, pre-op sedation |
| Therapeutic Effects | Increase HR, decrease secretions | Antiemetic, decrease secretions |
| Absorption | IV, IM | Transdermal, IM |
| Distribution | Cross BBB | Cross BBB |
| Metabolism/Excretion | Hepatic | Hepatic |
| ADE | Dry mouth, blurred vision, urinary retention, constipation | Drowsiness, dry mouth, blurred vision |
| Nurse Consideration | Monitor HR, urinary output | Educate on patch use, CNS side effects |
반응형
'In Canada > nursing study' 카테고리의 다른 글
| English of the Day: Something you pitch... you (7) | 2025.08.08 |
|---|---|
| Nursing Medication Card - Dantrolene (Dantrium) (Kor/Eng) (3) | 2025.08.05 |
| Nursing Medication Card – General Anesthetic Agents (Kor/Eng) (0) | 2025.08.01 |
| Nursing Medication Card – Allopurinol (Zyloprim) 알로퓨리놀 (자일로프림) (Kor/Eng) (5) | 2025.07.30 |
| Nursing Medication Card – Indomethacin (Indocin) / 인도메타신 (인도신) (Kor/Eng) (2) | 2025.07.28 |